论文信息 - The PARSC trial, a prospective study for the assessment of recurrence risk in stage II colon cancer (CC) patients using ColoPrint. - 字舞流文

The PARSC trial, a prospective study for the assessment of recurrence risk in stage II colon cancer (CC) patients using ColoPrint.

R. Salazar | J. Marshall | R. Rosenberg | F. Bibeau | B. Glimelius | J. Klaase | J. V. D. van der Hoeven | J. Capdevila | L. Stork-Sloots | J. D. de Waard